Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-11

Clinical Trial Update: Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating potential development of photoallergic skin reactions to MC2-01 cream has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MC2-01 Cream

Snippet

Sponsor: MC2 Therapeutics | Conditions: Photoallergy | Phase 1 | Status: COMPLETED | Results posted: 2020-03-11